Shalin Pandya is a Rheumatology/Immunology physician affiliated with Kaiser Permanente. OpenAlex indexes 8 publications with 444 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1528 Eureka Rd Ste 102
Roseville, CA 956613047
Telephone
167-366-6449Provider last certified this registry record 14 Apr 2025.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cochlear AmericasProgram year20252 payments
- AERIN MEDICAL INC.Program year20251 payment
- Ionis Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
86.4%Histamine-1 Receptor Antagonist39%Azelastine Hcl100%Part D≥91 patientsCorticosteroid32.4%Fluticasone Propionate63%Symbicort20%Breyna18%Part D<11 patients+ 4 more classes in this area
Dermatology
10.8%Interleukin-4 Receptor alpha Antagonist10.8%Dupixent Pen100%Part D<11 patientsMetabolism & gastrointestinal
2.8%Corticosteroid2.8%Prednisone100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Risk factors associated with treated acute-onset hypersensitivity reactions after COVID-19 mRNA vaccinations
Journal of Allergy and Clinical Immunology
2022 - Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination–Associated Hypersensitivity Reactions
The Journal of Allergy and Clinical Immunology In Practice
2021 - Use of Continuous Glucose Monitoring in Detecting Reactive Hypoglycemia in Individuals Without Diabetes
Journal of Diabetes Science and Technology
2018 - Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.
PubMed
2017 - Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
Frontiers in Immunology
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Presti, MD
Kaiser Permanente
Walter Kinney, MD
Kaiser Permanente
Alexander Flint, MD, PhD
Kaiser Permanente
Jonathan Zaroff, MD
Kaiser Permanente
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”